The FCC remand, the FDA’s legal duty, the WHO–ICNIRP conflict, and the urgent need for safer connected technology
America is at a defining moment on wireless radiation.
For more than three decades, the public has been told that wireless radiation safety is settled. Cell phones, Wi-Fi, cell towers, smart devices, Bluetooth, wearables, tablets, routers, smart meters, and 5G infrastructure have expanded into every part of daily life under a regulatory framework built around a narrow question: does radiofrequency radiation heat tissue too much?
That framework is no longer adequate.
The science has changed. The technology has changed. The exposure environment has changed. The cancer and bioeffects evidence has changed. The legal landscape has changed. And now, with the FDA leadership question before the country, Congress has a direct responsibility to demand that federal law be followed.
This is not an anti-technology argument. It is a pro-health, pro-science, pro-accountability argument.
The issue is simple: public health cannot be outsourced to a spectrum regulator, a telecom-friendly standards network, or an international body whose independence is now under serious question.
The FCC is not a medical agency. The WHO is not beyond scrutiny. ICNIRP is not an independent substitute for American law. And the FDA cannot continue to issue or tolerate public-facing assurances that outrun the evidence while the agency’s own statutory radiation-control responsibilities sit in the background.
Congress already created the legal framework. Public Law 90-602, enacted in 1968 and now codified in the Federal Food, Drug, and Cosmetic Act, gave HHS/FDA responsibility over electronic product radiation. FDA’s own legal summary explains that “electronic product radiation” includes non-ionizing electromagnetic radiation, and that electronic products include items with electronic circuits that emit such radiation, including cordless and cellular telephones.
The law directs the HHS Secretary to establish and carry out an electronic product radiation-control program to protect public health and safety. That program includes performance standards, research, exposure evaluation, public information, and procedures to minimize unnecessary radiation exposure.
That law did not expire when smartphones arrived. It did not disappear when Wi-Fi entered classrooms. It did not become irrelevant when the FCC auctioned spectrum. It applies now.
And Congress must enforce it.
The CHD petition makes FCC noncompliance impossible to ignore
Children’s Health Defense has now filed a new federal case seeking to force the FCC to comply with the 2021 D.C. Circuit remand. The petition asks the U.S. Court of Appeals for the D.C. Circuit to issue a writ of mandamus directing the FCC to comply within 90 days, to provide a 45-day status update, and to stop moving forward with wireless-infrastructure acceleration initiatives until the agency complies with the court’s order.
This is not a minor procedural fight. It is a major public-health accountability issue.
In 2019, the FCC decided to keep its 1996 radiofrequency exposure limits unchanged. CHD, Environmental Health Trust, and others challenged that decision. They argued that the FCC ignored thousands of pages of evidence on harm from wireless radiation. In 2021, the D.C. Circuit remanded the FCC’s decision, finding the agency’s explanation legally inadequate. The court said the FCC had failed to provide a reasoned explanation for its conclusion that its guidelines adequately protect against harmful effects of radiofrequency exposure unrelated to cancer.
The official court opinion is even more important. The D.C. Circuit explained that the FCC’s guidelines were last meaningfully updated in 1996 and that the agency had failed to adequately address evidence involving non-cancer effects, children, long-term exposure, radiofrequency pulsation and modulation, technological developments such as 5G, the ubiquity of wireless devices, and environmental harms.
That ruling should have triggered a serious national reassessment.
Instead, the country has continued building, deploying, authorizing, and normalizing wireless exposure while the underlying health-protection framework remains legally and scientifically unresolved.
That is the danger: regulatory expansion without regulatory accountability.
The FCC is a spectrum agency, not a medical agency
The FCC licenses spectrum. It manages communications infrastructure. It promotes deployment. It auctions access to the public airwaves.
It is not a toxicology agency. It is not a pediatric-health agency. It is not an oncology agency. It is not a reproductive-health agency. It is not the agency Congress designed to carry out the federal electronic-product radiation-control program.
That responsibility lies with HHS and FDA.
FDA’s own public page states that FDA shares regulatory responsibilities for cell phones with the FCC and provides scientific input and expertise to the FCC on radiofrequency energy. FDA also states that it is responsible for collecting, analyzing, and making available scientific information about hazards and control of electronic-product radiation.
That makes FDA’s silence and over-reassurance unacceptable.
If the FCC relies on federal health agencies to justify RF exposure limits, then FDA/HHS must provide a current, medically defensible, transparent health-risk assessment. They cannot stand behind the FCC while the FCC stands behind conclusory FDA statements. That is circular regulation, not public-health protection.
The FCC remand exposed the problem. The CHD petition now brings the unresolved problem back before the court. Congress must bring it into the open.
Public Law 90-602 is not optional
Public Law 90-602 was written for exactly this kind of problem: a technology becomes widespread, exposure becomes unavoidable, and the public needs federal health protection before preventable harm becomes normalized.
The law covers electronic product radiation, including non-ionizing electromagnetic radiation. FDA’s own examples include cordless and cellular telephones.
Under 21 U.S.C. § 360ii, HHS must establish and carry out an electronic product radiation-control program. That program includes developing and administering performance standards, supporting research, evaluating emissions and exposure conditions, developing procedures to minimize exposure, and making public information available about hazards and controls.
Under 21 U.S.C. § 360kk, the Secretary must prescribe performance standards for electronic products when necessary to protect public health and safety, taking into account the latest available scientific and medical data.
Those words matter.
“Latest available scientific and medical data” does not mean 1996 assumptions. It does not mean thermal-only thinking. It does not mean waiting for the telecom industry to agree. It does not mean pretending children, pregnant women, fertility, chronic exposure, modulation, pulsed signals, and cumulative whole-body exposure are secondary issues.
The law requires action.
The next FDA Commissioner should be required to explain, on the record, how FDA will enforce these duties. Senators should not confirm another FDA leader who treats wireless radiation as someone else’s problem.
FDA leadership cannot repeat blanket assurances
FDA has recently been forced into a more complicated posture on cell-phone radiation safety.
Reuters reported in January 2026 that HHS would launch a study on cellphone radiation and that FDA had removed older webpages saying cellphones are not dangerous. HHS stated that FDA removed old conclusions while the department undertook work to identify knowledge gaps involving electromagnetic radiation and modern technologies.
Yet FDA’s current public cell-phone page still contains broad reassurance language, including the statement that the “weight of scientific evidence has not linked cell phone radio frequency radiation with any health problems.”
That contradiction is the problem.
FDA cannot quietly remove outdated blanket assurances while continuing to communicate as if the issue is settled. The public deserves a clear explanation: what changed, what evidence is unresolved, what studies FDA is relying on, what studies it is discounting, and how the agency interprets its legal duty under Public Law 90-602.
This matters even more because the National Toxicology Program’s cell-phone radiofrequency studies were originally nominated by FDA due to widespread use and limited knowledge about long-term effects. NTP found clear evidence of malignant heart schwannomas in male rats, some evidence of malignant gliomas in male rats, and some evidence of adrenal-gland tumors. NTP also reported DNA-damage findings in specific tissues.
Then came the retreat. NTP now states that its follow-up exposure system was technically difficult, resource-intensive, and not representative of newer technologies such as 4G, 4G-LTE, or 5G. It also states that no further work with that RFR exposure system will be conducted and that NIEHS has no further plans to conduct additional RFR exposure studies at this time.
That is not a reason for inaction. It is a reason for Congress to intervene.
If the old federal research system is obsolete, then the answer is to modernize the research — not abandon it.
The next FDA Commissioner must be a confirmation test
This is not merely a personnel question. It is a statutory compliance question.
Any nominee for FDA Commissioner should be required to answer whether FDA/HHS will enforce the electronic-product radiation law Congress enacted. The issue is not whether the nominee can manage pharmaceuticals, food, vaping, drug approvals, or agency politics. The issue is whether the nominee will enforce the parts of FDA law that have been allowed to fade from public view while wireless exposure became a condition of modern life.
The next FDA Commissioner must commit to a written Public Law 90-602 compliance review. FDA/HHS should explain within 90 days how the agency is currently carrying out its electronic-product radiation duties, including research, exposure evaluation, performance standards, public communication, and exposure-minimization programs.
The next Commissioner must commit to an independent RF-EMF health-risk assessment. That assessment must include chronic exposure, non-thermal biological effects, children, pregnancy, reproductive health, cancer, oxidative stress, DNA damage, modulation, pulsation, cumulative indoor exposure, and environmental effects.
The next Commissioner must commit to restoring or replacing the discontinued federal RF research program. If NTP’s old exposure system is no longer representative of modern wireless technologies, Congress should require a modern program that studies 4G, 5G, 6G-relevant frequencies, Wi-Fi, wearables, tablets, routers, smart meters, and real-world chronic low-level exposure.
The next Commissioner must commit to formally advising the FCC in response to the 2021 remand. The FCC should not be allowed to rely on vague health-agency assurances. FDA/HHS must provide a current medical and toxicological analysis responsive to the court’s concerns.
The next Commissioner must commit to correcting public-facing safety language. FDA should not imply certainty where the scientific record shows unresolved risk, major animal findings, discontinued federal research, contested epidemiology, and legally remanded exposure limits.
No nominee should be confirmed until these commitments are made publicly.
The WHO–ICNIRP problem cannot be ignored
The United States has formally exited the World Health Organization. HHS states that the U.S. withdrawal was based on concerns including WHO’s failures during COVID-19, lack of reform, and lack of accountability, transparency, and independence.
Those same governance concerns matter in wireless radiation.
WHO openly identifies ICNIRP — the International Commission on Non-Ionizing Radiation Protection — as the body whose EMF exposure limits are formally recognized by WHO. WHO also states that exposures below ICNIRP’s recommended limits do not appear to have known health consequences and that WHO began a process of worldwide harmonization of EMF standards.
That makes ICNIRP one of the most powerful gatekeepers in global wireless-radiation policy.
The problem is that WHO-commissioned wireless reviews have been authored by people tied directly to the same standard-setting network. The 2024 WHO-commissioned human observational review on RF exposure and cancer listed Ken Karipidis as lead author and Dan Baaken as a coauthor. That review concluded that mobile-phone RF exposure likely does not increase the risk of several tumor categories, including glioma, meningioma, acoustic neuroma, pituitary tumors, salivary-gland tumors, and pediatric brain tumors.
But Karipidis is not outside the ICNIRP system. ICNIRP’s own website says he joined ICNIRP in 2015 and has served as ICNIRP Vice Chair since July 2024.
Baaken is also inside the ICNIRP system. ICNIRP states that he has served as Scientific Secretary since July 2024 and is a member of the ICNIRP Board together with the Chair and Vice Chair.
That is not genuine independence.
When the people connected to the standard-setting system write the reviews used to defend the standard-setting system, the public is not getting independent science. The public is getting a closed network grading its own homework.
Critics have called this out directly. ICBE-EMF argues that the Karipidis WHO review is flawed and should not be treated as proof of safety. ICBE specifically identifies ICNIRP-linked authors, criticizes reliance on weak exposure proxies such as cell-phone subscription studies, and argues that the review fails to properly account for latency and heavy long-term use.
This is why Congress should not allow WHO or ICNIRP to substitute for American statutory duties. The United States has its own law. The FDA and HHS have their own obligations. The Senate has its own confirmation authority. The court has already remanded the FCC’s old rationale.
America does not need another self-reinforcing international review to tell us that nothing must change.
America needs independent science.
The thermal-only model is outdated
The old regulatory model treats RF radiation primarily as a heating issue. If the exposure does not heat tissue beyond a defined threshold, the public is told it is safe.
That assumption is no longer enough.
Even FDA-regulated medicine recognizes that low-level, non-thermal, amplitude-modulated RF fields can be biologically active. The TheraBionic P1 record is important for that reason. FDA approved a handheld RF electromagnetic-field device for advanced hepatocellular carcinoma, and FDA’s own safety documentation describes low-level amplitude-modulated RF electromagnetic fields that do not result in thermal heating in the brain or other organs.
That does not mean a cancer-treatment device is the same as a cell phone. It means FDA cannot claim that non-thermal RF biology is impossible while accepting non-thermal RF biological interaction in a regulated medical-device context.
Signal structure matters. Frequency matters. Modulation matters. Pulsation matters. Timing matters. Biological state matters. Chronic exposure matters.
Wireless safety policy must finally catch up.
The evidence base has changed
The scientific record no longer supports the old “nothing to see here” posture.
The NTP findings are one major warning signal.
The Ramazzini Institute’s far-field base-station animal study is another independent warning signal, with overlapping tumor concerns reported in a different exposure model.
A WHO-commissioned animal-cancer systematic review has been reported as finding high-certainty evidence for key animal tumor endpoints, including glioma risk and malignant heart schwannomas in male rats.
Ronald Melnick and Joel Moskowitz’s 2026 Environmental Health paper applied benchmark-dose and conventional risk-assessment methods to animal cancer and reproductive data. The paper concluded that current FCC/ICNIRP public whole-body limits are 15- to 900-fold higher than their estimates for exposure associated with a 1-in-100,000 cancer risk, depending on exposure duration, and 8- to 24-fold higher than levels they estimate would protect male reproductive health.
That does not mean every scientific dispute is over. It means the old basis for inaction is gone.
The real question is whether FDA is performing the risk assessment Congress required.
The tumor trends cannot be brushed aside
Population data now add to the urgency.
Joel Moskowitz’s May 2026 analysis of National Cancer Institute SEER 21 data highlights significant age-adjusted increases since 2000 in several head-and-neck tumor categories relevant to wireless-device exposure. The data are age-adjusted, meaning the trends are not simply explained by the population getting older.
Non-malignant meningioma, the most common brain tumor, rose from 6.59 per 100,000 in 2004 to 12.18 per 100,000 in 2023. The increase persisted in young adults ages 15–39 and middle-aged adults ages 40–64.
Thyroid cancer doubled from 7.65 per 100,000 in 2000 to 15.35 per 100,000 in 2023, with a renewed increase from 2021 to 2023.
Salivary-gland cancer increased significantly from 2000 to 2023, rising 0.73% per year.
Glioblastoma was relatively stable overall, but that overall average masks important age-specific trends: young adults ages 15–39 increased 1.12% per year from 2000 to 2019, and adults 75 and older increased 0.60% per year since 2000.
These population trends do not need to be exaggerated to matter. They are already serious.
The public was told that real-world cancer data would be the final defense of the old safety narrative. Now the data are showing increases in phone-proximal tumor categories, while animal studies, risk assessments, and court rulings are all pointing in the same direction: the current system is not adequate.
Section 704 created preemption without protection
Congress also needs to confront Section 704 of the Telecommunications Act.
Section 704 prevents state and local governments from regulating the placement, construction, or modification of wireless facilities on the basis of the environmental effects of radiofrequency emissions, as long as the facilities comply with FCC regulations.
That structure creates a dangerous one-two punch.
Local governments are blocked from acting on RF health and environmental concerns. Meanwhile, the federal exposure framework is outdated, legally remanded, and dependent on health-agency assurances that have not been updated through a modern FDA-led risk assessment.
That is not public-health protection. That is preemption without protection.
If Congress silences local communities, then the federal government must provide current, independent, medically grounded safety standards. If the federal government refuses to do that, then Section 704 must be repealed or amended.
At minimum, Section 704 should not preempt local health and environmental decision-making while federal RF exposure limits remain under judicial remand or have not been updated through a current FDA/HHS medical risk assessment.
This is where Congress must lead
Congress cannot treat this as a niche issue.
Every school has wireless exposure. Every hospital has wireless exposure. Every workplace has wireless exposure. Every home has wireless exposure. Children are exposed before they understand consent. Pregnant women are exposed without individualized evaluation. People with medical implants, neurological conditions, sleep disruption, fertility concerns, cancer history, and electromagnetic sensitivity are given no meaningful accommodation in most environments.
And the public is told not to worry because the device complies with FCC limits.
That answer is no longer good enough.
Congress should immediately require:
- A formal FDA/HHS Public Law 90-602 compliance report.
- A modern independent RF-EMF health-risk assessment.
- A replacement for the discontinued NTP RFR research program.
- A formal FDA/HHS response to the 2021 FCC remand.
- Correction of public-facing FDA safety language.
- A genuinely independent scientific advisory panel with no ICNIRP pipeline dominance.
- A review of Section 704’s preemption of local health decision-making.
- Procurement standards that reduce unnecessary indoor wireless exposure.
- A national safer-technology transition plan for schools, homes, workplaces, and public buildings.
These are not radical demands. They are the minimum steps required to make federal law meaningful.
A Clean Ether agenda: safer connectivity without sacrificing technology
This debate must not be framed as technology versus health.
America does not need to abandon connectivity. America needs cleaner connectivity.
Just as the country removed lead from gasoline and reduced toxic exposures without ending transportation, Congress can reduce unnecessary pulsed microwave exposure without ending modern communication.
That starts indoors.
Schools, homes, workplaces, libraries, hospitals, and government buildings should not be saturated with wireless signals when safer and faster wired or light-based alternatives can be used. Ethernet should be the default for fixed devices. Fiber should be expanded. Wired connections should be restored where wireless convenience has replaced safer infrastructure.
And Congress should begin a national transition toward Li-Fi compatibility.
Li-Fi uses light to transmit data rather than radiofrequency microwave signals. IEEE has already developed the 802.11bb standard for light communications, creating a formal pathway for wireless connectivity using optical rather than RF transmission.
Li-Fi is not a total replacement for all outdoor mobile communication. But it can dramatically reduce unnecessary indoor RF exposure. It is especially relevant in classrooms, nurseries, homes, offices, medical settings, and other controlled indoor spaces where devices are stationary or semi-stationary.
Congress should create a “Clean Ether” framework: wired-first, fiber-first, Li-Fi-compatible, and wireless-last where feasible.
That means:
- New federally funded school technology should be wired or Li-Fi-compatible wherever practical.
- Routers in classrooms should be replaced with low-exposure infrastructure.
- Public buildings should prioritize Ethernet, fiber, and optical wireless systems.
- Children should not be used as involuntary test subjects for all-day wireless saturation.
- Federal procurement should drive the market toward safer devices.
- Manufacturers should be required to build Li-Fi compatibility into future laptops, tablets, phones, and educational devices.
- Wireless should remain available where necessary, but unnecessary indoor microwave exposure should be engineered downward.
This is the same principle America has used before: identify a preventable exposure, create a safer standard, and let innovation solve the problem.
The WHO cannot be America’s shield
The WHO–ICNIRP structure should not be used to shield U.S. agencies from their own duties.
WHO recognition of ICNIRP does not repeal Public Law 90-602. ICNIRP conclusions do not erase the FCC remand. WHO reviews do not override the NTP findings. International harmonization does not replace independent American health protection.
The United States left WHO because of governance failures, lack of reform, and concerns about accountability, transparency, and independence.
That same standard must now be applied to wireless radiation.
If a global health body relies heavily on a narrow standards network, and that standards network’s own members help author the reviews used to defend the standards, Congress should not treat those reviews as the final word. It should demand a genuinely independent review.
Not industry-friendly consensus.
Not closed-circle standard-setting.
Not thermal-only assumptions.
Not a review pipeline dominated by the same institutions that have defended the old limits for decades.
Independent science.
The responsibility now belongs to Congress
The court has spoken.
The FCC has not completed the public-health reassessment the remand demanded.
FDA/HHS have the statutory radiation-control responsibility.
NTP found serious animal cancer signals and then the federal research program stepped back.
FDA removed older blanket assurances while still maintaining broad reassurance language.
WHO relies on ICNIRP, and ICNIRP-linked authors are central to WHO-commissioned reviews used to defend the current exposure framework.
SEER data show increases in phone-proximal tumor categories.
Section 704 blocks local governments from acting on RF health and environmental concerns.
And now the next FDA Commissioner may be chosen without any serious public demand that FDA enforce the radiation law Congress already passed.
That cannot continue.
President Trump, Secretary Kennedy, and the Senate now have an opportunity to force the reset that should have happened years ago. The FDA Commissioner confirmation process must become a public test of whether the administration will enforce Public Law 90-602.
The next FDA Commissioner must be required to answer plainly:
Will FDA enforce the electronic-product radiation law?
Will FDA conduct a modern RF health-risk assessment?
Will FDA stop relying on outdated thermal-only assumptions?
Will FDA restore or replace federal RF exposure research?
Will FDA formally advise the FCC after the 2021 remand?
Will FDA correct public-facing safety claims that overstate certainty?
Will FDA protect children, pregnant women, fertility, and vulnerable populations?
Will FDA support a transition toward safer connectivity, including wired and Li-Fi-compatible infrastructure?
And will FDA finally tell the American people the truth: that wireless radiation safety is not settled, that the old limits are not modern, and that public health must come before industry convenience?
The bottom line
This is not about fear. It is about responsibility.
The country does not need to choose between technology and health. It needs technology designed around health.
The FCC cannot be allowed to act as both infrastructure promoter and de facto health protector. The WHO–ICNIRP network cannot be treated as independent enough to override American law. FDA cannot continue to act as if electronic-product radiation safety is someone else’s job. Congress cannot allow Section 704 to silence communities while federal standards remain outdated and legally challenged.
The law is already on the books.
The evidence is already serious.
The court has already acted.
The petition is now filed.
The next FDA Commissioner must be held to the standard Congress created.
Wireless radiation policy needs independence, transparency, modern science, enforceable law, and safer technology. America needs a Clean Ether agenda that reduces unnecessary pulsed microwave exposure in the places where children learn, families sleep, patients heal, and people work.
The era of denial must end.
Congress must act now.
